Lithotripsy Procedure
Description, Latest Information and Doctors

Save information for later
Sign Up

Learn About Lithotripsy

Who are the top Lithotripsy Local Doctors?
Elite in Lithotripsy
Elite in Lithotripsy

The Christ Hospital Physicians-Heart & Vascular

2123 Auburn Ave Ste 136, 
Cincinnati, OH 
Languages Spoken:
English

Dean Kereiakes is a Cardiologist practicing medicine in Cincinnati, Ohio. Dr. Kereiakes is rated as an Elite provider by MediFind in Lithotripsy. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Aortic Valve Stenosis, Angina, Lithotripsy, and Percutaneous Coronary Intervention (PCI).

Elite in Lithotripsy
Elite in Lithotripsy

Blood Draw Station-New Haven-Yale Physicians Building

800 Howard Ave Fl 2, 
New Haven,, CT 
Languages Spoken:
English
Offers Telehealth

Alexandra Lansky is a Cardiologist practicing medicine in New Haven,, Connecticut. Dr. Lansky is rated as an Elite provider by MediFind in Lithotripsy. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Heart Attack, Coronary Heart Disease, Acute Coronary Syndrome, Lithotripsy, and Percutaneous Coronary Intervention (PCI).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Lithotripsy
Elite in Lithotripsy

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10803 Falls Road, Pavilion III STE 3300, Pavilion III STE 3300, 
Lutherville, MD 
Languages Spoken:
English
Offers Telehealth

Dr. Brian Matlaga is a Professor of Urology at Johns Hopkins University School of Medicine and also is the Director of the Stephens Center for Stone Disease as well as the Executive Vice Chair of the James Buchanan Brady Urological Institute. Dr. Matlaga is an internationally recognized expert in the medical and surgical management of patients with urinary stone disease. A frequent contributor to the medical press, with over 180 peer-reviewed publications, Dr. Matlaga’s research has received national and international awards. Dr. Matlaga sits on numerous editorial boards as well as advisory committees and guidelines panels for the American Urological Association, the American Board of Urology, the Endourological Society, and the National Institutes of Health, amongst others. Dr. Matlaga serves as Executive Medical Director of Clinical Affairs for Johns Hopkins Medicine International, the arm of Johns Hopkins Medicine that manages its global presence. In this capacity, he delivers clinical care as well as project leadership across the globe. Dr. Matlaga is rated as an Elite provider by MediFind in Lithotripsy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Bladder Stones, Boils, Ureteroscopy, and Lithotripsy. Dr. Matlaga is board certified in American Board Of Urology.

What are the latest Lithotripsy Clinical Trials?
Optimum Time for Extracorporeal Shock Wave Lithotripsy for Residual Stones After Percutaneous Nephrolithotomy: A Prospective Comparative Randomized Study

Summary: Residual renal stone fragments remain a common clinical issue following percutaneous nephrolithotomy (PCNL), with reported incidence ranging from 10% to 30%. These fragments may act as a nidus for recurrent stone formation, infection, or obstruction, necessitating further intervention. Extracorporeal shock wave lithotripsy (ESWL) is widely used as a non-invasive treatment option for such residual ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Aggressive Intravenous Hydration With Lactated Ringer's Solution Plus Rectal Indometacin Versus Rectal Indometacin Alone to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy: A Multicentre, Superiority, Randomised, Controlled Trial

Summary: This study aims to determine whether combining aggressive intravenous hydration with indometacin is more effective at preventing pancreatitis after a Extracorporeal Shock Wave Lithotripsy (ESWL) than using indometacin alone. The study will involve patients who are scheduled to undergo ESWL for pancreatic stones. Participants will be randomly assigned to one of two groups: one will receive both the...